Jockers-Scherubl, MC; Bauer, A; Kuhn, S et al.
Nerve growth factor in serum is a marker of the stage of alcohol disease.Neurosci Lett. Bd. 419. H. 1. 2007 S. 78-82
Schmahl, C; Bohus, M; Esposito, F et al.
On determining sensitivity to pain in borderline personality disorderArch Gen Psychiatry. Bd. 64. 2007 S. 748-9
Hiemke, C; Baumann, P
Pharmakokinetik, Pharmakogenetikund therapeutisches Drug MonitoringHolsboer F., Gründer, G., Benkert, O. (Hrsg). Handbuch der Psychopharmakotherapie. 1. Aufl. Heidelberg: Springer 2007
Hiemke, C
Pharmakokinetik,Pharmakodynamik und InteraktionenBenkert, Hautzinger, Graf-Morgenstern (Hrsg). Psychopharmakologischer Leitfaden für Psychologen und Psychotherapeuten. 1. Aufl. Heidelberg: Springer 2007
Hiemke, C
Pharmakologische GrundlagenBenkert, Hautzinger, Graf-Morgenstern (Hrsg). Psychopharmakologischer Leitfaden für Psychologen und Psychotherapeuten. 1. Aufl. Heidelberg: Springer 2007
Tadic, A; Lieb, K
Pharmakotherapie bei therapieresistenter Depression. Neue Entwicklungen.Nervenarzt. Bd. 78 Suppl 3. 2007 S. 551-63; quiz 564
Vernaleken, I; Buchholz, HG; Kumakura, Y et al.
Prefrontal cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation.Hum Brain Mapp. Bd. 28. 2007 S. 931-939
Berg, C; Oeffner, A; Gerbert, B et al.
Prevalence of anterior pituitary dysfunction in patients following traumatic brain injury (TBI) in a German multi-centre screening program. 51. Annual Meeting of the German Society of EndocrinologyExp Clin Endocr Diab. Bd. 115. 2007 S. PO1-085
Fellgiebel, A; Albrecht, J; Dellani, PR et al.
Quantification of brain tissue alterations in Fabry disease using diffusion-tensor imagingActa Paediatr Suppl. Bd. 96. H. 455. 2007 S. 33-6
Kuhn, UD; Kirsch, M; Merkel, U et al.
Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans.Int J Clin Pharmacol Ther. Bd. 45. H. 1. 2007 S. 36-46